| CAT No: | CL-OZX-04 |
| CAS No: | NA |
| Mol.F: | C21H18D3N3O3 |
| Mol.Wt.: | 366.4 |
| Chemical Name: | 1-Cyclopropyl-8-methyl-7-(5-methyl-6-((methyl-d3)amino)pyridin-3-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
| Inventory Status: | Custom synthesis |
This impurity is related to Ozenoxacin D3 is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Ozenoxacin D3 is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:1-Cyclopropyl-8-methyl-7-(5-methyl-6-((methyl-d3)amino)pyridin-3-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acidCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Ozenoxacin Molecular Formula: C21H18D3N3O3
Molecular Weight: 366.4
Storage: Store in a cool, dry place.
| Product Name: | Ozenoxacin D3 |
| CAS No: | |
| Mol.F.: | C21H18D3N3O3 |
| Mol.Wt.: | 366.4 |
Cat. No: CL-OZX-NO-01
CAS No: NA
Mol. F: C18H16N4O4
Mol. Wt: 352.16
Inv. Status: Custom Synthesis
Cat. No: CL-OZX-NO-02
CAS No: NA
Mol. F: C29H29N7O7
Mol. Wt: 587.58
Inv. Status: Custom Synthesis
Cat. No: CL-OZX-NO-03
CAS No: NA
Mol. F: C15H19N3O7
Mol. Wt: 353.3
Inv. Status: Custom Synthesis
Cat. No: CL-OZX-01
CAS No: 245765-41-7
Mol. F: C21H21N3O3
Mol. Wt: 363.4
Inv. Status: Custom Synthesis
Cat. No: CL-OZX-02
CAS No: 446299-90-7
Mol. F: C30H29N3O4
Mol. Wt: 495.6
Inv. Status: Custom Synthesis
Cat. No: CL-OZX-03
CAS No: NA
Mol. F: C28H25N3O4
Mol. Wt: 467.5
Inv. Status: Custom Synthesis
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: